-
HCWB Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
HCW Biologics (HCWB)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 998.22 k | 998.22 k | 998.22 k | 998.22 k | 998.22 k | 998.22 k |
Cash burn (monthly) | 54.36 k | 851.88 k | 1.23 mm | 3.09 mm | 975.49 k | 1.27 mm |
Cash used (since last report) | 153.13 k | 2.40 mm | 3.46 mm | 8.71 mm | 2.75 mm | 3.59 mm |
Cash remaining | 845.09 k | -1.40 mm | -2.47 mm | -7.71 mm | -1.75 mm | -2.59 mm |
Runway (months of cash) | 15.5 | -1.6 | -2.0 | -2.5 | -1.8 | -2.0 |
13F holders | Current |
---|---|
Total holders | 12 |
Opened positions | 2 |
Closed positions | 3 |
Increased positions | 3 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 2.17 bn |
Total shares | 1.00 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
HighTower Advisors | 354.87 k | $770.00 mm |
Vanguard | 187.09 k | $405.99 mm |
Cresset Asset Management | 131.99 k | $286.42 mm |
Geode Capital Management | 131.03 k | $284.34 mm |
Bridgeway Capital Management | 82.60 k | $179.24 mm |
BLK BlackRock | 49.69 k | $107.82 mm |
Two Sigma Investments | 26.54 k | $57.59 mm |
STT State Street | 21.45 k | $46.54 mm |
NTRS Northern Trust | 10.21 k | $22.15 mm |
Tower Research Capital | 3.69 k | $8.01 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 24 | Gary M Winer | Stock Option Common Stock | Grant | Acquire A | No | No | 1.12 | 12,500 | 14.00 k | 12,500 |
14 Jun 24 | Rick S. Greene | Stock Option Common Stock | Grant | Acquire A | No | No | 1.12 | 12,500 | 14.00 k | 12,500 |
14 Jun 24 | Giles Lisa M. | Stock Option Common Stock | Grant | Acquire A | No | No | 1.12 | 12,500 | 14.00 k | 12,500 |
14 Jun 24 | Scott T Garrett | Stock Option Common Stock | Grant | Acquire A | No | No | 1.12 | 12,500 | 14.00 k | 12,500 |
20 Feb 24 | Giles Lisa M. | Common Stock | Grant | Acquire A | No | No | 1.4 | 35,715 | 50.00 k | 35,815 |